Preface |
|
xi | (2) |
Acknowledgments |
|
xiii | |
|
1. Toxicologic Pathology: An Introduction |
|
|
1 | (15) |
|
|
1 | (1) |
|
II. The Effect of the Body on the Chemical |
|
|
2 | (1) |
|
III. The Interaction of the Chemical and the Body |
|
|
3 | (1) |
|
IV. Pathology: The Response of the Body to Injury |
|
|
4 | (8) |
|
V. Morphologic Evaluation of Toxicity |
|
|
12 | (2) |
|
|
14 | (2) |
|
2. Chemical Carcinogenesis |
|
|
16 | (21) |
|
I. Nomenclature of Neoplasms |
|
|
16 | (1) |
|
II. Spectrum of Proliferative Lesions |
|
|
17 | (2) |
|
III. Steps in the Neoplastic Process |
|
|
19 | (3) |
|
IV. Hypotheses of Mode of Action of Chemical Carcinogens |
|
|
22 | (2) |
|
V. Oncogenes and Tumor Suppressor Genes in Chemical Carcinogenesis |
|
|
24 | (4) |
|
VI. Tests for Carcinogenic Potential of Chemicals |
|
|
28 | (4) |
|
|
1 | (32) |
|
|
32 | (1) |
|
|
33 | (4) |
|
|
37 | (20) |
|
|
37 | (17) |
|
|
37 | (1) |
|
II. Structure and Function of Skin |
|
|
38 | (3) |
|
III. Mechanisms of Cutaneous Toxicity |
|
|
41 | (4) |
|
IV. Response of Skin to Injury |
|
|
45 | (6) |
|
V. Evaluation of Cutaneous Toxicity |
|
|
51 | (3) |
|
|
54 | (2) |
|
|
54 | (1) |
|
II. Structure and Function of Oral Mucosa |
|
|
54 | (1) |
|
III. Mechanisms of Mucosal Toxicity |
|
|
54 | (1) |
|
IV. Response of Oral Mucosa to Injury |
|
|
54 | (2) |
|
V. Evaluation of Oral Toxicity |
|
|
56 | (1) |
|
|
56 | (1) |
|
4. Gastrointestinal Tract |
|
|
57 | (34) |
|
|
57 | (1) |
|
II. Structure and Function of Gastrointestinal Tract |
|
|
58 | (12) |
|
III. Mechanisms of Gastrointestinal Toxicity |
|
|
70 | (6) |
|
IV. Response of Gastrointestinal Tract to Injury |
|
|
76 | (10) |
|
V. Evaluation of Gastrointestinal Toxicity |
|
|
86 | (3) |
|
|
89 | (2) |
|
|
91 | (36) |
|
|
91 | (1) |
|
II. Structure and Cell Biology |
|
|
92 | (13) |
|
III. Mechanisms of Toxicity |
|
|
105 | (3) |
|
|
108 | (14) |
|
|
122 | (4) |
|
|
126 | (1) |
|
|
127 | (26) |
|
|
127 | (1) |
|
II. Structure and Function |
|
|
128 | (2) |
|
III. Cellular Mechanisms of Toxicity |
|
|
130 | (1) |
|
IV. Nonneoplastic Responses to Injury |
|
|
131 | (14) |
|
|
145 | (4) |
|
|
149 | (2) |
|
VII. Summary and Conclusions |
|
|
151 | (1) |
|
|
151 | (2) |
|
|
153 | (41) |
|
|
153 | (1) |
|
II. Renal Structure and Function |
|
|
154 | (8) |
|
III. Mechanisms of Toxicity |
|
|
162 | (21) |
|
|
183 | (5) |
|
V. Testing for Kidney and Urinary Tract Toxicity |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
191 | (3) |
|
|
194 | (21) |
|
PART I. EXOCRINE PANCREAS |
|
|
194 | (10) |
|
|
194 | (1) |
|
II. Normal Structure of Exocrine Pancreas |
|
|
194 | (1) |
|
III. Physiology of Exocrine Pancrease |
|
|
195 | (2) |
|
IV. Mechanisms of Exocrine Pancreatic Toxicity |
|
|
197 | (1) |
|
V. Response of Exocrine Pancreas to Injury |
|
|
197 | (5) |
|
VI. Evaluation of Exocrine Pancreatic Toxicity |
|
|
202 | (2) |
|
VII. Summary and Conclusions |
|
|
204 | (1) |
|
PART II. ENDOCRINE PANCREAS |
|
|
204 | (9) |
|
I. Structure of Endocrine Pancreas |
|
|
204 | (3) |
|
II. Physiology of Endocrine Pancreas |
|
|
207 | (1) |
|
III. Mechanisms of Endocrine Pancreatic Toxicity |
|
|
208 | (2) |
|
IV. Response of Endocrine Pancreas to Injury |
|
|
210 | (2) |
|
V. Evaluation of Endocrine Pancreatic Toxicity |
|
|
212 | (1) |
|
VI. Summary and Conclusions |
|
|
212 | (1) |
|
|
213 | (2) |
|
|
215 | (18) |
|
|
215 | (1) |
|
II. Structure and Cell Biology |
|
|
215 | (7) |
|
III. Mechanisms of Toxicity |
|
|
222 | (1) |
|
|
223 | (7) |
|
V. Evaluation of Bone Marrow Toxicity |
|
|
230 | (1) |
|
VI. Summary and Conclusions |
|
|
231 | (1) |
|
|
232 | (1) |
|
|
233 | (42) |
|
|
233 | (1) |
|
II. Function and Structure of the Immune System |
|
|
234 | (13) |
|
III. Mechanisms of Toxicity and Response to Injury |
|
|
247 | (11) |
|
IV. Morphology of the Response to Toxic Injury |
|
|
258 | (11) |
|
V. Testing for Immunotoxicity |
|
|
269 | (3) |
|
|
272 | (1) |
|
|
272 | (3) |
|
|
275 | (35) |
|
|
275 | (1) |
|
II. Skeletal Structure and Composition |
|
|
276 | (2) |
|
III. Bone Physiology and Function |
|
|
278 | (3) |
|
IV. Mechanisms of Toxicity |
|
|
281 | (6) |
|
V. Response of the Skeleton to Toxic Injury |
|
|
287 | (15) |
|
VI. Evaluation of Skeletal Toxicity |
|
|
302 | (5) |
|
|
307 | (1) |
|
|
308 | (2) |
|
12. Cardiovascular and Skeletal Muscle Systems |
|
|
310 | (45) |
|
|
310 | (25) |
|
|
310 | (1) |
|
II. Structure and Function |
|
|
310 | (5) |
|
III. Mechanisms of Toxicity |
|
|
315 | (6) |
|
|
321 | (10) |
|
|
331 | (4) |
|
|
335 | (10) |
|
|
335 | (1) |
|
II. Structure and Function |
|
|
335 | (2) |
|
III. Mechanisms of Toxicity |
|
|
337 | (3) |
|
|
340 | (3) |
|
V. Evaluation of Vasotoxic Effects |
|
|
343 | (2) |
|
PART III. SKELETAL MUSCLE |
|
|
345 | (8) |
|
|
345 | (1) |
|
II. Structure and Function |
|
|
345 | (2) |
|
III. Mechanisms of Toxicity |
|
|
347 | (2) |
|
|
349 | (3) |
|
V. Evaluation of the Effects of Xenobiotics on Skeletal Muscle |
|
|
352 | (1) |
|
|
353 | (2) |
|
|
355 | (40) |
|
|
355 | (1) |
|
II. Structure and Function |
|
|
356 | (6) |
|
III. Mechanisms of Toxicity |
|
|
362 | (4) |
|
|
366 | (25) |
|
|
391 | (1) |
|
VI. Use of Animals as Models for Human Neurotoxicity |
|
|
392 | (1) |
|
|
393 | (2) |
|
|
395 | (48) |
|
|
395 | (1) |
|
|
396 | (11) |
|
|
407 | (4) |
|
|
411 | (3) |
|
|
414 | (4) |
|
VI. Thyroid Follicular Cells |
|
|
418 | (17) |
|
|
435 | (6) |
|
|
441 | (2) |
|
15. Male Reproductive System |
|
|
443 | (42) |
|
|
443 | (1) |
|
II. Structure and Cell Biology |
|
|
444 | (16) |
|
III. Physiology and Functional Considerations |
|
|
460 | (4) |
|
IV. Mechanisms of Toxicity |
|
|
464 | (4) |
|
|
468 | (9) |
|
|
477 | (6) |
|
|
483 | (1) |
|
|
483 | (2) |
|
16. Female Reproductive System |
|
|
485 | (30) |
|
|
485 | (1) |
|
II. Structure and Functional Physiology |
|
|
486 | (8) |
|
III. Mechanisms of Toxicity |
|
|
494 | (7) |
|
|
501 | (11) |
|
|
512 | (2) |
|
|
514 | (1) |
|
|
514 | (1) |
|
|
515 | (28) |
|
|
515 | (1) |
|
II. Normal Morphologic Development |
|
|
516 | (3) |
|
III. Mechanisms of Toxicity |
|
|
519 | (3) |
|
|
522 | (6) |
|
V. Selected Malformations |
|
|
528 | (10) |
|
VI. Teratogenicity Testing and Risk Assessment |
|
|
538 | (3) |
|
|
541 | (1) |
|
|
541 | (2) |
Index |
|
543 | |